The Epstein–Barr Virus Receptor is Distinct from the C3 Receptor

References

1. Abu Sinna G., Lundgren E., Nilsson K., Roos G. 1980; Isozymes of amino acid naphthylamidase in human haemapoietic cell lines. British Journal of Haematology 44:25–32
   [Google Scholar]
2. Epstein M. A., Achong B. (editors) 1979; The Epstein-Barr virus. Berlin, Heidelberg & New York: Springer-Verlag;
   [Google Scholar]
3. Epstein M. A., Achong B., Barr Y., Zajac B., Henle G., Henle W. 1966; Morphological and virological investigation of cultured Burkitt tumor lymphoblasts (strain Raji). Journal of the National Cancer Institute 37:547–559
   [Google Scholar]
4. Fresen K., Zur Hausen H. 1976; Establishment of EBNA-expressing cell lines by infection of EBV-genome negative human lymphoma cells with different EBV strains. International Journal of Cancer 17:161–166
   [Google Scholar]
5. Gerdes J., Stein H. 1981; Human membrane-bound C3 receptors. II. Physicochemical properties of the C3b and C3d receptors isolated from tonsil cells by immunoprecipitation. Scandinavian Journal of Immunology 13:77–86
   [Google Scholar]
6. Gerdes J., Stein H., Dierich M. P., Conrad D. H. 1982; Antisera with anti-pan C3 receptor reactivity which block complement C3b, C3bi and C3d receptors. Journal of Immunological Methods 51:259–265
   [Google Scholar]
7. Jondal M., Klein G., Oldstone M., Bokish V., Yefenof E. 1976; Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells. Scandinavian Journal of Immunology 5:401–410
   [Google Scholar]
8. Jønsson V., Wells A., Klein G. 1982; Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively co-expressed on a series of B-cell lines and their derived somatic cell hybrids. Cellular Immunology 72: (in press)
   [Google Scholar]
9. Klein G., Yefenof E., Falk K., Westman A. 1978; Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt’s lymphoma. International Journal of Cancer 21:552–560
   [Google Scholar]
10. Klein G., Manneborg A., Steinitz M. 1979; Differences in EBV receptor concentration between in vitro EBV-converted lymphoma sublines reflect biological differences between the converting viral substrains. International Journal of Cancer 23:197–200
    [Google Scholar]
11. Koide N., Wells A., Volsky D., Shapiro I., Klein G. 1981; The detection of Epstein-Barr virus receptors utilizing radiolabelled virus. Journal of General Virology 54:191–195
    [Google Scholar]
12. Lambris D. J., Dobson N. J., Ross G. D. 1981; Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody. Proceedings of the National Academy of Sciences of the United States of America 78:1828–1832
    [Google Scholar]
13. Nilsson K., Sundstrom C. 1974; Establishment and characteristics of two unique cell lines from patients with lymphosarcoma. International Journal of Cancer 13:808–823
    [Google Scholar]
14. Stein H., Gerdes J., Tolksdorf G., Klatt U. 1981; Human membrane-bound C3 receptors. I. Serological and immunohistological demonstration of C3 receptors. Scandinavian Journal of Immunology 13:67–76
    [Google Scholar]
15. Wells A., Koide N., Klein G. 1981; Difference in viral binding between two Epstein-Barr virus substrains to a spectrum of receptor-positive target cells. International Journal of Cancer 27:303–309
    [Google Scholar]
16. Yefenof E., Klein G. 1977; Membrane receptor stripping confirms the association between EBV receptors and complement receptors on the surface of human B lymphoma lines. International Journal of Cancer 20:347–352
    [Google Scholar]
17. Yefenof E., Klein G., Jondal M., Oldstone M. 1976; Surface markers on human B and T lymphocytes. IX. Two color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cells lines. International Journal of Cancer 17:693–700
    [Google Scholar]
18. Yefenof E., Klein G., Kvarnung K. 1977; Relationship between complement activation, complement binding, and EBV absorption by human hemapoietic cell lines. Cellular Immunology 31:225–233
    [Google Scholar]